Regentis Biomaterials ratios data for the quarter ended Dec 2025. These financial ratios cover 2 quarters of results from Dec 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2024 | Dec2025 |
|---|---|---|
| Efficiency | ||
| Assets AverageAssets Avg. | 4.05M | |
| Invested CapitalInvested Cap. | -36.16M | 7.14M |
| Leverage & Solvency | ||
| Debt Ratio | 10.26 | 0.31 |
| Valuation | ||
| Price to BookP/B | 0.81 | |
| Enterprise Value | -3.56M | |
| Market Capitalization | 3.82M |